In an animal study, SRC activation led to collagen accumulation and the mitogen-activated protein kinase (MAPK) signaling pathway, suggesting that it might be a therapeutic target for diabetic nephropathy [38]. This evidence concerns the gene WNK2 and diabetic kidney disease.